RK Mellon Foundation Pledges $25M to Launch Rare Disease Therapy Hub in Pittsburgh

RK Mellon Foundation pledges $25M to launch rare disease therapy hub in Pittsburgh

An ambitious program meant to establish a Pittsburgh-based hub to fasttrack new therapies for rare diseases is bringing together $25 million, a collection...

The Galien Foundation Announces 2026 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Product," and "Best Product for Rare/Orphan Diseases"

A Milestone 20th Anniversary Edition Recognizing Excellence in Medical Science and Patient Care

Rare Ventures, a First-of-its-kind Platform for Accelerating Rare Disease Therapies, Launches in Pittsburgh

Carnegie Mellon University is a founding partner in a Pittsburgh-based partnership that brings together leaders in medicine, biotechnology and artificial intelligence to speed the development of treatments for rare diseases.